Skip to main content
PRTA logo
PRTA
(NASDAQ)
Prothena Corporation plc
$9.55-- (--)
Loading... - Market loading

Prothena Corporation (PRTA) Stock Price & Financial Analysis

Prothena Corporation Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.12 - $9.77
52-Week High$11.80
52-Week Low$5.83
Open$9.12
Volume458.04K
Average Volume (3M)574.51K
Market Cap516.74M
Shares Outstanding54.11M
Price to Sales (P/S)8.92
Price to Book (P/B)1.65
EV/EBITDA-2.49
Revenue (TTM)57.94M
Net Income (TTM)-151.18M
Free Cash Flow (TTM)-81.43M
EPS (TTM)$-2.80
Profit Margin-260.92%
Operating Margin-160.84%
Return on Equity (ROE)-48.36%
Debt to Equity0.02
50-Day MA$9.83
200-Day MA$9.65
52-Week Change57.59%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Prothena Corporation

What is the current stock price for PRTA?

As of the latest trading session, PRTA stock trades at $9.55. The 52-week range is $5.83–$11.80, with a day range of $9.12–$9.77.

What is the P/E ratio for PRTA?

The P/E ratio (Price-to-Earnings) for PRTA is shown in the Key Statistics section. This valuation metric helps compare Prothena Corporation plc to industry peers.

Does PRTA pay dividends?

Prothena Corporation does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRTA?

Based on 5 analysts, the consensus for PRTA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PRTA?

Prothena Corporation's market capitalization is $516.7M, classifying it as a small-cap company. Prothena Corporation operates in the Healthcare sector within the Biotechnology industry.